Face Transplantation

Current Problems in Surgery

Volumn 48, Issue 5, 2011, Pages 293-357

  Pomahac, Bohdan ^a   Nowinski, Daniel ^b   Diaz Siso, J Rodrigo ^a   Bueno, Ericka M ^a   Talbot, Simon G ^c   Sinha, Indranil ^d   Westvik, Tormod S ^d   Vyas, Raj ^d   Singhal, Dhruv ^d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2 RECEPTOR MONOCLONAL ANTIBODY; LYMPHOBLAST ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN; METHYLPREDNISOLONE; MINOR HISTOCOMPATIBILITY ANTIGEN; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ACUTE GRAFT REJECTION; ANOREXIA; ARTICLE; CANCER GROWTH; CANCER INCIDENCE; CHRONIC GRAFT REJECTION; CONGENITAL DISORDER; CONSTIPATION; DIABETES MELLITUS; DIARRHEA; DONOR SELECTION; DRUG DOSE REDUCTION; ESTHETIC SURGERY; FACE BURN; FACE INJURY; FACE MALFORMATION; FACIAL EXPRESSION; FACIAL TRANSPLANTATION; GLUCOSE INTOLERANCE; GRAFT SURVIVAL; HEAD AND NECK CANCER; HEADACHE; HEALTH CARE COST; HEMATOLOGIC DISEASE; HISTOCOMPATIBILITY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMAGING; IMMUNOLOGICAL TOLERANCE; INFECTION; INFORMED CONSENT; INSOMNIA; NAUSEA; NEPHROTOXICITY; NEW ONSET DIABETES MELLITUS; NONHUMAN; OPPORTUNISTIC INFECTION; PARESTHESIA; PATIENT SELECTION; PLEURA EFFUSION; POSTOPERATIVE COMPLICATION; PSYCHOSOCIAL DISORDER; RISK BENEFIT ANALYSIS; SIDE EFFECT; SURGICAL APPROACH; SURGICAL INFECTION; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING; TREMOR; VOMITING;

DONOR SELECTION; FACIAL TRANSPLANTATION; HUMANS; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; RECONSTRUCTIVE SURGICAL PROCEDURES;

EID: 79953272872     PISSN: 00113840     EISSN: None     Source Type: Journal    
DOI: 10.1067/j.cpsurg.2011.01.003     Document Type: Article

References (201)

1. Devauchelle B., Badet L., Lengele B., et al. First Human Face Allograft: early report. Lancet 2006, 368:203-209.
2. Dubernard J.M., Lengele B., Morelon E., et al. Outcomes 18 months after the first human partial face transplantation. N Engl J Med 2007, 357:2451-2460.
3. Guo S., Han Y., Zhang X., et al. Human facial allotransplantation: a 2-year follow-up study. Lancet 2008, 372:631-638.
4. Lantieri L., Meningaud J.P., Grimbert P., et al. Repair of the lower and middle parts of the face by composite tissue allotransplantation in a patient with massive plexiform neurofibroma: a 1-year follow-up study. Lancet 2008, 372:639-645.
5. Siemionow M., Papay F., Alam D., et al. Near-total human face transplantation for a severely disfigured patient in the USA. Lancet 2009, 374:203-209.
6. O'Neill H., Godden D. Ethical issues of facial transplantation. Br J Oral Maxillofac Surg 2009, 47:443-445.
7. Aflaki P., Nelson C., Balas B., et al. Simulated central face transplantation: age consideration in matching donors and recipients. J Plast Reconstr Aesthet Surg 2010, 63:283-285.
8. Pomahac B., Aflaki P., Nelson C., et al. Evaluation of appearance transfer and persistence in central face transplantation: a computer simulation analysis. J Plast Reconstr Aesthet Surg 2010, 63:733-738.
9. Baccarani A., Follmar K.E., Das R.R., et al. A pilot study in sub-SMAs face transplantation: defining donor compatibility and assessing outcomes in a cadaver model. Plast Reconstr Surg 2007, 119:121-129.
10. Pomahac B., Pribaz J., Eriksson E., et al. Restoration of facial form and function after severe disfigurement from burn injury by a composite facial allograft. Am J Transplant 2011, 11:386-393.
11. Siemionow M., Agaoglu G., Unal S. A cadaver study in preparation for facial allograft transplantation in humans: Part II. mock facial transplantation. Plast Reconstr Surg 2006, 117:876-885. [Discussion 886-8].
12. Daly C.C. Saving face. South Med J 2006, 99:412-413.
13. Sinno H.H., Thibaudeau S., Duggal A., et al. Utility scores for facial disfigurement requiring facial transplantation [outcomes article]. Plast Reconstr Surg 2010, 126:443-449.
14. Siemionow M., Unal S., Agaoglu G., et al. A cadaver study in preparation for facial allograft transplantation in humans: Part I. What are alternative sources for total facial defect coverage?. Plast Reconstr Surg 2006, 117:864-872. [Discussion 873-5].
15. Siemionow M., Agaoglu G. Allotransplantation of the face: how close are we?. Clin Plast Surg 2005, 32:401-409. vii.
16. Peled Z.M., Pribaz J.J. Face transplantation: the view from harvard medical school. South Med J 2006, 99:414-416.
17. Washington K.M., Solari M.G., Sacks J.M., et al. A model for functional recovery and cortical reintegration after hemifacial composite tissue allotransplantation. Plast Reconstr Surg 2009, 123:26S-33S.
18. Furr L.A., Wiggins O., Cunningham M., et al. Psychosocial implications of disfigurement and the future of human face transplantation. Plast Reconstr Surg 2007, 120:559-565.
19. Petit F., Paraskevas A., Minns A.B., et al. Face transplantation: where do we stand?. Plast Reconstr Surg 2004, 113:1429-1433.
20. Losee J.E., Schneeberger S., Lee W.P. Discussion. First U.S. near-total human face transplantation: a paradigm shift for massive complex injuries. Plast Reconstr Surg 2010, 125:123-124.
21. Siemionow M., Demir Y., Mukherjee A., et al. Development and maintenance of donor-specific chimerism in semi-allogenic and fully major histocompatibility complex mismatched facial allograft transplants. Transplantation 2005, 79:558-567.
22. Siemionow M., Ozmen S., Demir Y. Prospects for facial allograft transplantation in humans. Plast Reconstr Surg 2004, 113:1421-1428.
23. Siemionow M., Klimczak A. Tolerance and future directions for composite tissue allograft transplants: Part II. Plast Reconstr Surg 2009, 123:7e-17e.
24. Siemionow M.Z., Zor F., Gordon C.R., et al. Upper extremity, and concomitant transplantation: potential concerns and challenges ahead. Plast Reconstr Surg 2010, 126:308-315.
25. Wigmore S.J. Face transplantation: the view from Birmingham, England. South Med J 2006, 99:424-426.
26. Siemionow M.Z., Kulahci Y., Bozkurt M. Composite tissue allotransplantation. Plast Reconstr Surg 2009, 124:e327-e339.
27. Pomahac B., Aflaki P., Chandraker A., et al. Facial Transplantation and immunosuppressed patients: a new frontier in reconstructive surgery. Transplantation 2008, 85:1693-1697.
28. Hettiaratchy S. Transplantation tolerance and chimerism: what are they and do we need them?. Plast Reconstr Surg 2004, 113:2213-2214.
29. Vasilic D., Alloway R.R., Barker J.H., et al. Risk assessment of immunosuppressive therapy in facial transplantation. Plast Reconstr Surg 2007, 120:657-668.
30. Walton R.L., Levin L.S. Face transplantation: the view from Duke University and the University of Chicago. South Med J 2006, 99:417-418.
31. Wimmer C.D., Rentsch M., Crispin A., et al. The janus face of immunosuppression-de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich. Kidney Int 2007, 71:1271-1278.
32. Barker J.H., Furr A., Cunningham M., et al. Investigation of risk acceptance in facial transplantation. Plast Reconstr Surg 2006, 118:663-670.
33. Meningaud J.P., Paraskevas A., Ingallina F., et al. Face transplant graft procurement: a preclinical and clinical study. Plast Reconstr Surg 2008, 122:1383-1389.
34. Hutchison I. Face transplants: is the genie out of the bottle?. South Med J 2006, 99:427-429.
35. Siemionow M.Z., Papay F., Djohan R., et al. First U.S. near-total human face transplantation: a paradigm shift for massive complex injuries. Plast Reconstr Surg 2010, 125:111-122.
36. Hamdy R.C. Face transplantation: a brave or maverick surgery?. South Med J 2006, 99:410-411.
37. The French position: Comite Consultatif National d'Ethique pour les Sciences de la Vie et De La Sante: "Composite Tissue Allograftransplantation of the Face (Total or Partial Graft).". South Med J 2006, 99:432-433.
38. Diver A.J. Investigation of risk acceptance in facial transplantation. Plast Reconstr Surg 2007, 119:2317. [Author reply].
39. Vasilic D., Reynolds C.C., Cunningham M., et al. Plastic surgeon's risk acceptance in facial transplantation. Plast Reconstr Surg 2008, 121:41e-48e.
40. Rohrich R.J., Longaker M.T., Cunningham B. On the ethics of composite tissue allotransplantation (facial transplantation). Plast Reconstr Surg 2006, 117:2071-2073.
41. Chung K.C., Oda T., Saddawi-Konefka D., et al. An economic analysis of hand transplantation in the United States. Plast Reconstr Surg 2010, 125:589-598.
42. The United States position: position paper of the American Society for Reconstructive Microsurgery on Facial Transplantation. South Med J 2006, 99:430.
43. Daar A.S., Fuggle S.V., Fabre J.W., et al. The detailed distribution of MHC Class II antigens in normal human organs. Transplantation 1984, 38:293-298.
44. Hayry P., von Willebrand E., Parthenais E., et al. The inflammatory mechanisms of allograft rejection. Immunol Rev 1984, 77:85-142.
45. Simpson E., Scott D., James E., et al. Minor H antigens: genes and peptides. Transpl Immunol 2002, 10:115-123.
46. Barth R., Counce S., Smith P., et al. Strong and weak histocompatibility gene differences in mice and their role in the rejection of homografts of tumors and skin. Ann Surg 1956, 144:198-204.
47. Simpson E., Roopenian D., Goulmy E., et al. Histocompatibility Antigens. Immunol Today 1998, 19:108-112.
48. Simpson E.M. Transplantation antigens: mouse models for human host-versus-graft, graft-versus-host and graft-versus-leukemia reactions. Arch Immunol Ther Exp 1998, 46:331-339.
49. Fraser C.J., Scott Baker K. The management and outcome of chronic graft-versus-host disease. Br J Haematol 2007, 138:131-145.
50. Fangmann J., Dalchau R., Sawyer G.J., et al. T cell recognition of donor major histocompatibility complex class I peptides during allograft rejection. Eur J Immunol 1992, 22:1525-1530.
51. Benichou G. Direct and indirect antigen recognition: the pathways to allograft immune rejection. Front Biosci 1999, 4:D476-D480.
52. Fondevila C., Busuttil R.W., Kupiec-Weglinski J.W. Hepatic ischemia/reperfusion injury-a fresh look. Exp Mol Pathol 2003, 74:86-93.
53. Alegre M.L., Florquin S., Goldman M. Cellular mechanisms underlying acute graft rejection: time for reassessment. Curr Opin Immunol 2007, 19:563-568.
54. Tilney N.L., Guttmann R.D. Effects of initial ischemia/reperfusion injury on the transplanted kidney. Transplantation 1997, 64:945-947.
55. Suthanthiran M., Strom T.B. Renal transplantation. N Engl J Med 1994, 331:365-376.
56. Afzali B., Lechler R.I., Hernandez-Fuentes M.P. Allorecognition and the alloresponse: clinical implications. Tissue Antigens 2007, 69:545-556.
57. Shimizu A., Colvin R.B. Pathological features of antibody-mediated rejection. Curr Drug Targets Cardiovasc Haematol Disord 2005, 5:199-214.
58. Matthew J.M., Ruiz P. Immunopathology of organ transplantation. Transplantation Pathology 2009, 1-25. Cambridge University Press, New York, NY. P. Ruiz (Ed.).
59. Ibrahim S., Dawson D.V., Sanfilippo F. Predominant infiltration of rejecting human renal allografts with T cells expressing CD8 and CD45RO. Transplantation 1995, 59:724-728.
60. Matheson P.J., Dittmer I.D., Beaumont B.W., et al. The macrophage is the predominant inflammatory cell in renal allograft intimal arteritis. Transplantation 2005, 79:1658-1662.
61. Sykes M. Immune tolerance: mechanisms and application in clinical transplantation. J Intern Med 2007, 262:288-310.
62. Mathis D., Benoist C. Back to central tolerance. Immunity 2004, 20:509-516.
63. Petruzzo P., Lanzetta M., Dubernard J.M., et al. The international registry on hand and composite tissue transplantation. Transplantation 2008, 86:487-492.
64. Mathes D.W., Randolph M.A., Solari M.G., et al. Split tolerance to a composite tissue allograft in a swine model. Transplantation 2003, 75:25-31.
65. Davis W.C., McKenzie I.F., Melvold R.W. A comparison of skin and heart graft rejection patterns in H-2 mutant mice. Transplantation 1980, 29:189-192.
66. Cendales L., Hardy M.A. Immunologic considerations in composite tissue transplantation: overview. Microsurgery 2000, 20:412-419.
67. Dvorak H.F., Mihm M.C., Dvorak A.M., et al. The microvasculature is the critical target of the immune response in vascularized skin allograft rejection. J Invest Dermatol 1980, 74:280-284.
68. Bhan A.K., Harrist T.J., Murphy G.F., et al. T cell subsets and Langerhans cells in Lichen planus: in situ characterization using monoclonal antibodies. Br J Dermatol 1981, 105:617-622.
69. Whitaker I.S., Duggan E.M., Alloway R.R., et al. Composite tissue allotransplantation: a review of relevant immunological issues for plastic surgeons. J Plast Reconstr Aesthet Surg 2008, 61:481-492.
70. Gorantla V.S., Barker J.H., Jones J.W., et al. Immunosuppressive agents in transplantation: mechanisms of action and current anti-rejection strategies. Microsurgery 2000, 20:420-429.
71. Splendiani G., Cipriani S., Tisone G., et al. Infectious complications in renal transplant recipients. Transplant Proc 2005, 37:2497-2499.
72. McKane W., Kanganas C., Preston R., et al. Treatment of calcineurin inhibitor toxicity by dose reduction plus introduction of mycophenolate mofetil. Transplant Proc 2001, 33:1224-1225.
73. Vicari-Christensen M., Repper S., Basile S., et al. Tacrolimus: review of pharmacokinetics, pharmacodynamics, and pharmacogenetics to facilitate practitioners' understanding and offer strategies for educating patients and promoting adherence. Prog Transplant 2009, 19:277-284.
74. Fishman J.A. Infection in renal transplant recipients. Semin Nephrol 2007, 27:445-461.
75. Parasuraman R., Yee J., Karthikeyan V., et al. Infectious complications in renal transplant recipients. Adv Chronic Kidney Dis 2006, 13:280-294.
76. Lanzetta M., Petruzzo P., Margreiter R., et al. The International Registry on Hand and Composite Tissue Transplantation. Transplantation 2005, 79:1210-1214.
77. Nalesnik M.A. Clinicopathologic features of posttransplant lymphoproliferative disorders. Ann Transplant 1997, 2:33-40.
78. Kasiske B.L., Snyder J.J., Gilbertson D.T., et al. Cancer after kidney transplantation in the United States. Am J Transplant 2004, 4:905-913.
79. Landin L., Cavadas P.C., Ibanez J., et al. Malignant skin tumor in a composite tissue (bilateral hand) allograft recipient. Plast Reconstr Surg 2010, 125:20e-21e.
80. Lanzetta M., Petruzzo P., Dubernard J.M., et al. Second report (1998-2006) of the International Registry of Hand and Composite Tissue Transplantation. Transpl Immunol 2007, 18:1-6.
81. Gordon C.R., Siemionow M., Papay F., et al. The world's experience with facial transplantation: what have we learned thus far?. Ann Plast Surg 2009, 63:572-578.
82. Kean L.S., Gangappa S., Pearson T.C., et al. Transplant tolerance in non-human primates: progress, current challenges and unmet needs. Am J Transplant 2006, 6:884-893.
83. Hawksworth J.S., Leeser D., Jindal R.M., et al. New directions for induction immunosuppression strategy in solid organ transplantation. Am J Surg 2009, 197:515-524.
84. Golshayan D., Pascual M. Tolerance-inducing immunosuppressive strategies in clinical transplantation: an overview. Drugs 2008, 68:2113-2130.
85. Sykes M. Mixed chimerism and transplant tolerance. Immunity 2001, 14:417-424.
86. Kawai T., Sogawa H., Boskovic S., et al. CD154 Blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates. Am J Transplant 2004, 4:1391-1398.
87. Kawai T., Poncelet A., Sachs D.H., et al. Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance. Transplantation 1999, 68:1767-1775.
88. Thomas J.M., Eckhoff D.E., Contreras J.L., et al. Durable donor-specific T and B cell tolerance in rhesus macaques induced with peritransplantation anti-CD3 immunotoxin and deoxyspergualin: absence of chronic allograft nephropathy. Transplantation 2000, 69:2497-2503.
89. Bluestone J.A., Thomson A.W., Shevach E.M., et al. What does the future hold for cell-based tolerogenic therapy?. Nat Rev Immunol 2007, 7:650-654.
90. Chatenoud L. CD3-specific antibody-induced active tolerance: from bench to bedside. Nat Rev Immunol 2003, 3:123-132.
91. Siemionow M., Oke R., Ozer K., et al. Induction of donor-specific tolerance in rat hind-limb allografts under antilymphocyte serum and cyclosporine A protocol. J Hand Surg Am 2002, 27:1095-1103.
92. Siemionow M.Z., Izycki D.M., Zielinski M. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol. Transplantation 2003, 76:1662-1668.
93. Foster R.D., Liu T. Orthotopic hind limb transplantation in the mouse. J Reconstr Microsurg 2003, 19:49-52. [Discussion 43-4].
94. Wekerle T. T-regulatory cells-what relationship with immunosuppressive agents?. Transplant Proc 2008, 40:S13-S16.
95. Adamson L.A., Huang W.C., Breidenbach W.C., et al. A modified model of hindlimb osteomyocutaneous flap for the study of tolerance to composite tissue allografts. Microsurgery 2007, 27:630-636.
96. Tung T.H., Mohanakumar T., Mackinnon S.E. Development of a mouse model for heterotopic limb and composite-tissue transplantation. J Reconstr Microsurg 2001, 17:267-273.
97. Zhang F., Shi D.Y., Kryger Z., et al. Development of a mouse limb transplantation model. Microsurgery 1999, 19:209-213.
98. Zhong T., Liu Y., Jiang J., et al. Long-term limb allograft survival using a short course of anti-CD45rb monoclonal antibody, Lf 15-0195, and rapamycin in a mouse model. Transplantation 2007, 84:1636-1643.
99. + T-cell depletion and rapamycin synergize with combined coreceptor/stimulation blockade to induce robust limb allograft tolerance in mice. Am J Transplant 2008, 8:2527-2536.
100. Netto M.V., Fonseca B.A., Dantas M., et al. Granzyme B, Fas-ligand and perforin expression during acute cellular rejection episodes after kidney transplantation: comparison between blood and renal aspirates. Transplant Proc 2002, 34:476-478.
101. Strehlau J., Pavlakis M., Lipman M., et al. The intragraft gene activation of markers reflecting T-cell-activation and -cytotoxicity analyzed by quantitative RT-PCR in renal transplantation. Clin Nephrol 1996, 46:30-33.
102. Li B., Hartono C., Ding R., et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger rna for perforin and granzyme B in urine. N Engl J Med 2001, 344:947-954.
103. Sabek O., Dorak M.T., Kotb M., et al. Quantitative detection of T-cell activation markers by real-time PCR in renal transplant rejection and correlation with histopathologic evaluation. Transplantation 2002, 74:701-707.
104. Matsui Y., Saiura A., Sugawara Y., et al. Identification of gene expression profile in tolerizing murine cardiac allograft by costimulatory blockade. Physiol Genomics 2003, 15:199-208.
105. Brouard S., Mansfield E., Braud C., et al. Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci U S A 2007, 104:15448-15453.
106. Muthukumar T., Dadhania D., Ding R., et al. Messenger RNA for Foxp3 in the urine of renal-allograft recipients. N Engl J Med 2005, 353:2342-2351.
107. Seiler M., Brabcova I., Viklicky O., et al. Heightened expression of the cytotoxicity receptor Nkg2d correlates with acute and chronic nephropathy after kidney transplantation. Am J Transplant 2007, 7:423-433.
108. Vasconcellos L.M., Schachter A.D., Zheng X.X., et al. Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts. Transplantation 1998, 66:562-566.
109. Dugre F.J., Gaudreau S., Belles-Isles M., et al. Cytokine and cytotoxic molecule gene expression determined in peripheral blood mononuclear cells in the diagnosis of acute renal rejection. Transplantation 2000, 70:1074-1080.
110. Shin G.T., Kim S.J., Lee T.S., et al. Gene expression of perforin by peripheral blood lymphocytes as a marker of acute rejection. Nephron Clin Pract 2005, 100:c63-c70.
111. Simon T., Opelz G., Wiesel M., et al. Serial peripheral blood perforin and granzyme B gene expression measurements for prediction of acute rejection in kidney graft recipients. Am J Transplant 2003, 3:1121-1127.
112. Veale J.L., Liang L.W., Zhang Q., et al. Noninvasive diagnosis of cellular and antibody-mediated rejection by perforin and granzyme B in renal allografts. Hum Immunol 2006, 67:777-786.
113. Shoker A., George D., Yang H., et al. Heightened CD40 ligand gene expression in peripheral CD4+ T cells from patients with kidney allograft rejection. Transplantation 2000, 70:497-505.
114. Deng M.C., Eisen H.J., Mehra M.R., et al. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 2006, 6:150-160.
115. Hoffmann S.C., Hale D.A., Kleiner D.E., et al. Functionally significant renal allograft rejection is defined by transcriptional criteria. Am J Transplant 2005, 5:573-581.
116. Sawitzki B., Bushell A., Steger U., et al. Identification of gene markers for the prediction of allograft rejection or permanent acceptance. Am J Transplant 2007, 7:1091-1102.
117. Cobbold S.P., Nolan K.F., Graca L., et al. Regulatory T cells and dendritic cells in transplantation tolerance: molecular markers and mechanisms. Immunol Rev 2003, 196:109-124.
118. Zelenika D., Adams E., Humm S., et al. Regulatory T cells overexpress a subset of Th2 gene transcripts. J Immunol 2002, 168:1069-1079.
119. Anglicheau D., Sharma V.K., Ding R., et al. MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci U S A 2009, 106:5330-5335.
120. Hollenbeck S.T., Erdmann D., Levin L.S. Current indications for hand and face allotransplantation. Transplant Proc 2009, 41:495-498.
121. Hui-Chou H.G., Nam A.J., Rodriguez E.D. Clinical facial composite tissue allotransplantation: a review of the first four global experiences and future implications. Plast Reconstr Surg 2010, 125:538-546.
122. Cole J.K., Engrav L.H., Heimbach D.M., et al. Early excision and grafting of face and neck burns in patients over 20 years. Plast Reconstr Surg 2002, 109:1266-1273.
123. Klein M.B., Moore M.L., Costa B., et al. Primer on the management of face burns at the University of Washington. J Burn Care Rehabil 2005, 26:2-6.
124. Achauer B.M. Reconstructing the burned face. Clin Plast Surg 1992, 19:623-636.
125. Parrett B.M., Pomahac B., Orgill D.P., et al. The role of free-tissue transfer for head and neck burn reconstruction. Plast Reconstr Surg 2007, 120:1871-1878.
126. Gurtner G.C., Evans G.R. Advances in head and neck reconstruction. Plast Reconstr Surg 2000, 106:672-682. [Quiz 683].
127. Cordeiro P.G., Disa J.J. Challenges in midface reconstruction. Semin Surg Oncol 2000, 19:218-225.
128. Hakim S.G., Jacobsen H.C., Aschoff H.H., et al. Including the platysma muscle in a cervicofacial skin rotation flap to enhance blood supply for reconstruction of vast orbital and cheek defects: anatomical considerations and surgical technique. Int J Oral Maxillofac Surg 2009, 38:1316-1319.
129. Gahhos F.N., Ariyan S., Cuono C.B., et al. Burn wound excision and local flap closure. Ann Plast Surg 1985, 14:535-540.
130. Dobratz E.J., Hilger P.A. Cheek defects. Facial Plast Surg Clin North Am 2009, 17:455-467.
131. Ahmad Q.G., Navadgi S., Agarwal R., et al. Pectoralis major myocutaneous flap in reconstructing full thickness defects of cheek: a review of 47 cases. J Plast Reconstr Aesthet Surg 2006, 59:166-173.
132. Davison S.P., Mesbahi A.N., Clemens M.W., et al. Vascularized calvarial bone flaps and midface reconstruction. Plast Reconstr Surg 2008, 122:10e-18e.
133. Moukarbel R.V., Fung K., Franklin J.H., et al. Neck and shoulder disability following reconstruction with the pectoralis major pedicled flap. Laryngoscope 2010, 120:1129-1134.
134. Merve A., Mitra I., Swindell R., et al. Shoulder morbidity after pectoralis major flap reconstruction for head and neck cancer. Head Neck 2009, 31:1470-1476.
135. Liu R., Gullane P., Brown D., et al. Pectoralis major myocutaneous pedicled flap in head and neck reconstruction: retrospective review of indications and results in 244 consecutive cases at the Toronto General Hospital. J Otolaryngol 2001, 30:34-40.
136. Hurvitz K.A., Kobayashi M., Evans G.R. Current options in head and neck reconstruction. Plast Reconstr Surg 2006, 118:122e-133e.
137. Muzaffar A.R., Adams W.P., Hartog J.M., et al. Maxillary reconstruction: functional and aesthetic considerations. Plast Reconstr Surg 1999, 104:2172-2183. [Quiz 2184].
138. Miller M.J., Robb G.L., Schusterman M.A. Microvascular reconstruction for cutaneous defects. Clin Plast Surg 1997, 24:769-778.
139. Disa J.J., Liew S., Cordeiro P.G. Soft-tissue reconstruction of the face using the folded/multiple skin island radial forearm free flap. Ann Plast Surg 2001, 47:612-619.
140. Mureau M.A., Posch N.A., Meeuwis C.A., et al. Anterolateral thigh flap reconstruction of large external facial skin defects: a follow-up study on functional and aesthetic recipient- and donor-site outcome. Plast Reconstr Surg 2005, 115:1077-1086.
141. Hidalgo D.A., Rekow A. A review of 60 consecutive fibula free flap mandible reconstructions. Plast Reconstr Surg 1995, 96:585-596. [Discussion 597-602].
142. Urken M.L., Bridger A.G., Zur K.B., et al. The scapular osteofasciocutaneous flap: a 12-year experience. Arch Otolaryngol Head Neck Surg 2001, 127:862-869.
143. Shpitzer T., Neligan P.C., Gullane P.J., et al. The free iliac crest and fibula flaps in vascularized oromandibular reconstruction: comparison and long-term evaluation. Head Neck 1999, 21:639-647.
144. Cordeiro P.G., Disa J.J., Hidalgo D.A., et al. Reconstruction of the mandible with osseous free flaps: A 10-year experience with 150 consecutive patients. Plast Reconstr Surg 1999, 104:1314-1320.
145. Foster R.D., Anthony J.P., Singer M.I., et al. Reconstruction of complex midfacial defects. Plast Reconstr Surg 1997, 99:1555-1565.
146. Cordeiro P.G., Santamaria E., Kraus D.H., et al. Reconstruction of total maxillectomy defects with preservation of the orbital contents. Plast Reconstr Surg 1998, 102:1874-1884. [Discussion 1885-7].
147. Wei F.C., Demirkan F., Chen H.C., et al. Double free flaps in reconstruction of extensive composite mandibular defects in head and neck cancer. Plast Reconstr Surg 1999, 103:39-47.
148. Kuzon W.M., Jejurikar S., Wilkins E.G., et al. Double free-flap reconstruction of massive defects involving the lip, chin, and mandible. Microsurgery 1998, 18:372-378.
149. Angrigiani C., Grilli D. Total face reconstruction with one free flap. Plast Reconstr Surg 1997, 99:1566-1575.
150. Latifoglu O., Ayhan S., Atabay K. Total face reconstruction: skin graft versus free flap. Plast Reconstr Surg 1999, 103:1076-1078.
151. Posch N.A., Mureau M.A., Dumans A.G., et al. Functional and aesthetic outcome and survival after double free flap reconstruction in advanced head and neck cancer patients. Plast Reconstr Surg 2007, 120:124-129.
152. Gabr E., Kobayashi M.R., Salibian A.H., et al. Mandibular reconstruction: are two flaps better than one?. Ann Plast Surg 2004, 52:31-35.
153. Burget G.C., Menick F.J. Aesthetic restoration of one-half the upper lip. Plast Reconstr Surg 1986, 78:583-593.
154. Jeng S.F., Kuo Y.R., Wei F.C., et al. Reconstruction of concomitant lip and cheek through-and-through defects with combined free flap and an advancement flap from the remaining lip. Plast Reconstr Surg 2004, 113:491-498.
155. Kroll S.S. Staged sequential flap reconstruction for large lower lip defects. Plast Reconstr Surg 1991, 88:620-625. [Discussion 626-7].
156. Cordeiro P.G., Santamaria E. Primary reconstruction of complex midfacial defects with combined lip-switch procedures and free flaps. Plast Reconstr Surg 1999, 103:1850-1856.
157. Furuta S., Sakaguchi Y., Iwasawa M., et al. Reconstruction of the lips, oral commissure, and full-thickness cheek with a composite radial forearm palmaris longus free flap. Ann Plast Surg 1994, 33:544-547.
158. Menick F.J. Facial reconstruction with local and distant tissue: the interface of aesthetic and reconstructive surgery. Plast Reconstr Surg 1998, 102:1424-1433.
159. Burget G.C., Walton R.L. Optimal use of microvascular free flaps, cartilage grafts, and a paramedian forehead flap for aesthetic reconstruction of the nose and adjacent facial units. Plast Reconstr Surg 2007, 120:1171-1207. [Discussion 1208-16].
160. Ariyan S. The pectoralis major myocutaneous flap. a versatile flap for reconstruction in the head and neck. Plast Reconstr Surg 1979, 63:73-81.
161. Kroll S.S., Reece G.P., Robb G., et al. Cervicofacial rotation-advancement flap for reconstruction of large cheek defects. Plast Reconstr Surg 1994, 94:88-93.
162. Santamaria E., Cordeiro P.G. Reconstruction of maxillectomy and midfacial defects with free tissue transfer. J Surg Oncol 2006, 94:522-531.
163. Pribaz J.J., Prelamination F.N.A. Defining the prefabricated flap-a case report and review. Microsurgery 1994, 15:618-623.
164. Pribaz J.J., Weiss D.D., Mulliken J.B., et al. Free flap reconstruction of complex central facial defects. Plast Reconstr Surg 1999, 104:357-365. [Discussion 366-7].
165. Gonzalez-Ulloa M. Restoration of the face covering by means of selected skin in regional aesthetic units. Br J Plast Surg 1956, 9:212-221.
166. Pomahac B., Lengele B., Ridgway E.B., et al. Vascular considerations in composite midfacial allotransplantation. Plast Reconstr Surg 2010, 125:517-522.
167. Sastry S.M., Sastry C.M., Paul B.K., et al. Leading causes of facial trauma in the major trauma outcome study. Plast Reconstr Surg 1995, 95:196-197.
168. Lee S. Facial soft tissue. Trauma 2009, Accessed October 1, 2010. http://emedicine.medscape.com/article/882081-overview.
169. Ryan C.M., Schoenfeld D.A., Thorpe W.P., et al. Objective estimates of the probability of death from burn injuries. N Engl J Med 1998, 338:362-366.
170. Pushpakumar S.B., Barker J.H., Soni C.V., et al. Clinical considerations in face transplantation. Burns 2010, 36:951-958.
171. Salinas N.L., Faulkner J.A. Facial trauma in operation Iraqi freedom casualties: an outcomes study of patients treated from April 2006 through October 2006. J Craniofac Surg 2010, 21:967-970.
172. Wade A.L., Dye J.L., Mohrle C.R., et al. Head, face, and neck injuries during Operation Iraqi Freedom II: Results from the US Navy-Marine Corps Combat Trauma Registry. J Trauma 2007, 63:836-840.
173. Owens B.D., Kragh J.F., Wenke J.C., et al. Combat wounds in Operation Iraqi Freedom and Operation Enduring Freedom. J Trauma 2008, 64:295-299.
174. Kauvar D.S., Wolf S.E., Wade C.E., et al. Burns sustained in combat explosions in Operations Iraqi and Enduring Freedom (OIF/OEF Explosion Burns). Burns 2006, 32:853-857.
175. Hivelin M., Wolkenstein P., Lepage C., et al. Facial aesthetic unit remodeling procedure for neurofibromatosis type 1 hemifacial hypertrophy: report on 33 consecutive adult patients. Plast Reconstr Surg 2010, 125:1197-1207.
176. Peltonen J., Jaakkola S., Lebwohl M., et al. Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis. Lab Invest 1988, 59:760-771.
177. Lengele B.G. Current concepts and future challenges in facial transplantation. Clin Plast Surg 2009, 36:507-521.
178. Washington K.M., Zanoun R.R., Cadogan K.A., et al. Composite tissue allotransplantation for the reconstruction of congenital craniofacial defects. Transplant Proc 2009, 41:523-527.
179. Cordeiro P.G. Frontiers in free flap reconstruction in the head and neck. J Surg Oncol 2008, 97:669-673.
180. Barogui Y., Johnson R.C., van der Werf T.S., et al. Functional limitations after surgical or antibiotic treatment for buruli ulcer in Benin. Am J Trop Med Hyg 2009, 81:82-87.
181. Enwonwu C.O., Falkler W.A., Noma P.R.S. (Cancrum oris). Lancet 2006, 368:147-156.
182. Wallace C.G., Wei F.C. The current status, evolution and future of facial reconstruction. Chang Gung Med J 2008, 31:441-449.
183. Dubernard J.M., Petruzzo P., Lanzetta M., et al. Functional results of the first human double-hand transplantation. Ann Surg 2003, 238:128-136.
184. Kasiske B.L., Ramos E.L., Gaston R.S., et al. The evaluation of renal transplant candidates: clinical practice guidelines. Patient Care and Education Committee of the American Society of Transplant Physicians. J Am Soc Nephrol 1995, 6:1-34.
185. Garcia-Miguel F.J., Serrano-Aguilar P.G., Lopez-Bastida J. Preoperative assessment. Lancet 2003, 362:1749-1757.
186. Soni C.V., Barker J.H., Pushpakumar S.B., et al. Psychosocial considerations in facial transplantation. Burns 2010, 36:959-964.
187. Morris P.J., Bradley J.A., Doyal L. Facial transplantation: a working party report from the Royal College of Surgeons of England. Transplantation 2004, 77:330-338.
188. Islam S., Ahmed M., Walton G.M., et al. The association between depression and anxiety disorders following facial trauma-a comparative study. Injury 2010, 41:92-96.
189. Rumsey N., Harcourt D. Body image and disfigurement: issues and interventions. Body Image 2004, 1:83-97.
190. Brill S.E., Clarke A., Veale D.M., et al. Psychological management and body image issues in facial transplantation. Body Image 2006, 3:1-15.
191. Kanitakis J., Jullien D., Petruzzo P., et al. Clinicopathologic features of graft rejection of the first human hand allograft. Transplantation 2003, 76:688-693.
192. Klapheke M.M., Marcell C., Taliaferro G., et al. Psychiatric assessment of candidates for hand transplantation. Microsurgery 2000, 20:453-457.
193. Dobbels F., Vanhaecke J., Dupont L., et al. Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening. Transplantation 2009, 87:1497-1504.
194. Pinsky B.W., Takemoto S.K., Lentine K.L., et al. Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. Am J Transplant 2009, 9:2597-2606.
195. Facial Transplantation-Asrm/Asps Guiding Principles Surgeons ASoP, 2006, Accessed August 31, 2010. http://www.microsurg.org/ftGuidelines.pdf.
196. Morris P., Bradley A., Doyal L., et al. Face transplantation: a review of the technical, immunological, psychological and clinical issues with recommendations for good practice. Transplantation 2007, 83:109-128.
197. Gordon C.R., Siemionow M., Coffman K., et al. The Cleveland Clinic Faces Score: a preliminary assessment tool for identifying the optimal face transplant candidate. J Craniofac Surg 2009, 20:1969-1974.
198. Baccarani A., Follmar K.E., Baumeister S.P., et al. Technical and anatomical considerations of face harvest in face transplantation. Ann Plast Surg 2006, 57:483-488.
199. Banks N.D., Hui-Chou H.G., Tripathi S., et al. An anatomical study of external carotid artery vascular territories in face and midface flaps for transplantation. Plast Reconstr Surg 2009, 123:1677-1687.
200. Alam D.S., Papay F., Djohan R., et al. The technical and anatomical aspects of the world's first near-total human face and maxilla transplant. Arch Facial Plast Surg 2009, 11:369-377.
201. Meningaud J.P., Benjoar M.D., Hivelin M., et al. The procurement of total human face graft for allotransplantation: a preclinical study and the first clinical case. Plast Reconstr Surg 2010 Jun 15, (Epub ahead of print).